Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.

par Griesbacher, T., Leighton, G. E., Hill, R. G., Hughes, J.
Publié 1989

The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin.

par Hewson, G., Leighton, G. E., Hill, R. G., Hughes, J.
Publié 1988

Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.

par Hewson, G., Leighton, G. E., Hill, R. G., Hughes, J.
Publié 1988

kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat.

par Leighton, G. E., Rodriguez, R. E., Hill, R. G., Hughes, J.
Publié 1988

Pharmacological profile of PD 117302, a selective kappa-opioid agonist.

par Leighton, G. E., Johnson, M. A., Meecham, K. G., Hill, R. G., Hughes, J.
Publié 1987

CI-977, a novel and selective agonist for the kappa-opioid receptor.

par Hunter, J. C., Leighton, G. E., Meecham, K. G., Boyle, S. J., Horwell, D. C., Rees, D. C., Hughes, J.
Publié 1990